Skip to content

Conventional Sacroiliac Joint Injection Versus Pulsed Radiofrequency in SIJ Pain

Unlocking Sacroiliac Joint Pain: A Comparative Study of Pulsed Radiofrequency and Conventional Technique

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07709689
Enrollment
80
Registered
2026-07-16
Start date
2026-07-12
Completion date
2027-09-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Sacroiliitis

Brief summary

Therapeutic options for SIJ pain include intra-articular corticosteroid injections, which provide symptomatic relief but typically require repeated administration due to variable and short-lived efficacy. More recently, pulsed radiofrequency (PRF) has been investigated for joint pain management through intra-articular electrode placement and stimulation. However, its effectiveness in treating SIJ pain remains insufficiently studied and warrants further exploration.

Interventions

PROCEDUREConventional injection

Sacroiliac joint (SIJ) steroid injection

PRF of Sacroiliac Joint (SIJ)

Sponsors

National Cancer Institute, Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Sacroiliac Joint (SIJ) Pain * Diagnostic Block Response: Demonstrated a pain reduction of at least 50% following a diagnostic intra- articular SIJ block. * Failure of Medical Management * Chronic Pain Duration: Presence of chronic pain for a minimum duration of 6 months. * Pain Intensity: A pain intensity score greater than 5 on a 10-point Numeric Rating Scale (NRS), where 0 represents no pain and 10 represents the worst imaginable pain. * Age: Aged between 18 and 65 years. * Body Mass Index (BMI): A BMI within the range of 20 kg/m² to 35 kg/m².

Exclusion criteria

* Patient refusal. * Local infection at the puncture site. * Coagulopathies with platelets count below 50,000 or an INR\>1.6. * Unstable cardiovascular disease and Poor general condition and severe respiratory distress. * History of psychiatric and cognitive disorders or opioid addiction. * Patients are allergic to medication used. * Previous surgery to the affected site. * Rheumatological disease such as rheumatoid arthtritis or ankylsoing spondyolitis.

Design outcomes

Primary

MeasureTime frameDescription
Numeric rating score (NRs) reduction1 monthNumeric rating score (NRs) reduction of pain scores after 1 month

Contacts

CONTACTWalaa Y Elsabeeny, MD
walaa.elsabeeny@nci.cu.edu.eg01007798466
CONTACTMohamed Magdy, MD
Mohammed.magdy@nci.cu.edu.eg01005562356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026